Kushwaha Sachin, Jawahar Varsha, Kumar Ajay, Griffin Lauren, Rothstein Thomas L, Sehgal Devinder, Khan Naeem
Molecular Immunology Laboratory, National Institute of Immunology, Aruna Asaf Ali Marg, New Delhi, India.
Center for Immunobiology, Western Michigan University Homer Stryker M. D. School of Medicine, Kalamazoo, MI, USA.
J Immunol Methods. 2025 Mar;538:113823. doi: 10.1016/j.jim.2025.113823. Epub 2025 Jan 31.
Human monoclonal antibodies (mAbs) are an important segment in precision therapeutics. Various methodologies are available for generating them. Recombinant human mAbs expression from sorted single B cells is preferred for its rapid expression using mammalian vectors while maintaining in vivo immunoglobulin (Ig) pairing. The success rate of generating recombinant mAbs from single sorted human B cells directly relies on Ig heavy (IgH) and light (IgL) gene coverage of the PCR primers. Existing primer sets fail to cover all functional human Ig gene rearrangements, exhibit high degeneracy leading to non-specific amplifications and mutations arising from primer mismatch/degeneracy, and require high amplification cycles. Some existing primer sets have high coverage but are not designed for expression as recombinant mAbs. Here, we have designed a primer set to amplify all functional V(D)J transcripts in human B cell repertoire using a nested RT-PCR approach. The resultant amplicons can be cloned into mammalian vectors for expression of recombinant mAb. Non-specific amplifications were minimized using isotype-specific primers for cDNA synthesis and limiting primer degeneracy. We validated the designed primers on single sorted B cells, bulk sorted B cells and peripheral blood mononuclear cells. We were successfully able to amplify paired heavy and light chain transcripts in 38.46 % (80/208) from naive, memory and B1 B cell subsets sorted as single B cells. Paired Ig transcripts from five single B cells were cloned into expression vectors and purified from mammalian cells as recombinant mAbs. Thus, our new primer set offers significant advantages over existing primers as it allows amplification of all functional V(D)J rearrangements, facilitating rapid generation of antigen-specific recombinant antibodies from diverse human B cell repertoires following vaccinations and infections previously inaccessible due to primer limitations.
人源单克隆抗体(mAb)是精准治疗领域的一个重要组成部分。有多种方法可用于生成人源单克隆抗体。从分选的单个B细胞中重组表达人源单克隆抗体是首选方法,因为它使用哺乳动物载体能快速表达,同时保持体内免疫球蛋白(Ig)配对。直接从分选的单个B细胞生成重组单克隆抗体的成功率直接依赖于PCR引物对免疫球蛋白重链(IgH)和轻链(IgL)基因的覆盖范围。现有的引物组无法覆盖所有功能性人类Ig基因重排,具有高度简并性,导致非特异性扩增以及引物错配/简并引起的突变,并且需要高扩增循环数。一些现有的引物组具有高覆盖率,但并非为重组单克隆抗体的表达而设计。在此,我们设计了一组引物,采用巢式RT-PCR方法扩增人类B细胞库中所有功能性V(D)J转录本。所得扩增产物可克隆到哺乳动物载体中用于重组单克隆抗体的表达。通过使用同型特异性引物进行cDNA合成并限制引物简并性,将非特异性扩增降至最低。我们在分选的单个B细胞、大量分选的B细胞和外周血单个核细胞上验证了所设计的引物。我们成功地从分选的单个B细胞中的初始、记忆和B1 B细胞亚群中扩增出38.46%(80/208)的配对重链和轻链转录本。来自五个单个B细胞的配对Ig转录本被克隆到表达载体中,并从哺乳动物细胞中纯化得到重组单克隆抗体。因此,我们的新引物组相对于现有引物具有显著优势,因为它能够扩增所有功能性V(D)J重排,有助于在接种疫苗和感染后从以前因引物限制而无法获取的多样化人类B细胞库中快速生成抗原特异性重组抗体。